Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod IncfiledCriticalPfizer Prod Inc
Priority to UY26785ApriorityCriticalpatent/UY26785A1/en
Publication of UY26785A1publicationCriticalpatent/UY26785A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invención se refiere a compuestos de fórmula , y a sales , solvatos o profármacos farmacéuticamente aceptable de los mismos, en los cuales R1,R3, R4, R5, R11, m y p son tales como se han definido en la presente memoria. La invención se refiere también a métodos para tratar el crecimiento celular anormal en animales mamíferos administrando los compuestos de fórmula 1, y a composiciones farmacéuticas para tratar transtornos, que contienen los compuestos de fórmula 1. La invención se refiere también a métodos para preparar los compuestos de fórmula 1.The invention relates to compounds of formula, and pharmaceutically acceptable salts, solvates or prodrugs thereof, in which R1, R3, R4, R5, R11, m and p are as defined herein. The invention also relates to methods for treating abnormal cell growth in mammalian animals by administering the compounds of formula 1, and pharmaceutical compositions for treating disorders, which contain the compounds of formula 1. The invention also relates to methods for preparing the compounds of Formula 1.
UY26785A2001-06-212001-06-21
SUBSTITUTED BICYCLIC DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH
UY26785A1
(en)
BENZONE-CONDENSED HETEROARILAMIDE TYENOPIRIDIN DERIVATIVES USED AS THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS, INCLUDING THEM, AND THEIR APPLICATION